Royal Bank of Canada
FMED icon

Royal Bank of Canada’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Royal Bank of Canada’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80
Closed -$2K – 7513
2026
Q1 		$2K Buy
+80
New +$2.08K ﹤0.01% 6694

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $793M AUM 21.06% 1-Year Est. Return

Royal Bank of Canada's FMED Position: Q2 2026 in Review

Royal Bank of Canada sold out of Fidelity Disruptive Medicine ETF (FMED) in Q2 2026, closing a stake of 80 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in FMED in Q1 2026 and held it in 1 quarter. The position peaked at $2K in Q1 2026. 11 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

  • Royal Bank of Canada reported no remaining Fidelity Disruptive Medicine ETF position as of Q2 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 80 Fidelity Disruptive Medicine ETF shares in Q2 2026, an estimated $2K.
  • Royal Bank of Canada first reported a position in Fidelity Disruptive Medicine ETF in Q1 2026 and held it in 1 quarter.
  • Royal Bank of Canada's Fidelity Disruptive Medicine ETF position peaked at $2K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.